April, 2018 | BioBarica Profesionales

April 2018

23
Apr

Hyperbaric Oxygen Therapy Can Induce Angiogenesis and Regeneration of Nerve Fibers in Traumatic Brain Injury Patients

The  post-concussion  syndrome  (PCS)  is  a  complex  of symptoms  consisting  of  headaches,  dizziness,  imbalance,  vertigo, fatigue,  changes  in  sleep  pattern,  neuropsychiatric  symptoms,  and  cognitive impairments  (in  memory,  attention,  concentration  and  executive functions). PCS  is  most  often  described  in the  setting  of  mTBI,  but  may  also  occur  after  moderate  and  severe TBI.  In  Eight  to  Ninty  percent  of  mTBI  cases,  the 

Read more

19
Apr

BioBarica is a finalist for the Med-Tech Innovation’s Advancing Healthcare award

Four finalists have been picked from the exhibitors who entered the inaugural Advancing Healthcare award at this year’s Med-Tech Innovation Expo The new category was established by the editorial team behind Med-Tech Innovation News, the leading publication for the UK’s medical device market. The finalists are BioBarica, a manufacturer of hyperbaric chambers, Bluefrog Design, a product design consultancy, contract manufacturer

Read more

19
Apr

BioBarica present at Exposanitá 2018

From April 18th to 20th, BioBarica is in the Stand C60 of Exposanitá 2018, an event that presents the latest generation of services, products and solutions that companies and industry professionals study, design and innovate every day to make the administration of medical care more efficient and the process of attention of the person more effective. The fair is a

Read more

13
Apr

Cerebral oxygenation and the recoverable brain

Stroke is the third leading cause of death in the United States and a major source of disability. It is not only devastating to the patient and the family, but also creates a large financial drain on resources. In stroke it is often stated that most recovery takes place in the first three months. However, sequential SPECT scanning has indicated

Read more

11
Apr

Parkinson’s disease: Case studies showing success treating it with HBOT

5 patients with a history of Parkinson’s disease (PD) were treated with Hyperbaric Oxygen Therapy (HBOT) for 1 hour at 1.5-2.0 ATA. All 5 patients reported a decrease in tremors and an improvement in general well-being. The patients underwent an initial course of 10 treatments and were allowed to continue treatment as needed until they perceived a plateau in benefit.

Read more

9
Apr

BioBarica supported the first Workshop on Normobaric and Hyperbaric Oxygen Therapy in Bahía Blanca

On april 6th it was held the first Workshop on Normobaric and Hyperbaric Oxygen Therapy in the Assembly Hall of the Hospital Italiano Regional del Sur in Bahía Blanca, Argentina. The workshop was aimed to health professionals, students, nurses, doctors, kinesiologists, biochemists, pharmacists, technicians and bioengineers. It also counted with the organization and the presence of several specialists with experience

Read more

4
Apr

Hyperbaric oxygen effects on sports injuries

In the last decade, competitive sports have taken on a whole new meaning, where intensity has increased together with the incidence of injuries to the athletes. Therefore, there is a strong need to develop better and faster treatments that allow the injured athlete to return to competition faster than with the normal course of rehabilitation, with a low risk of

Read more

3
Apr

What effects can hyperbaric treatment have on patients with autism?

Autistic Spectrum Disorders (ASD) affect the development of the nervous system and brain functioning, especially in aspects related to the processing of information that comes from social stimuli. It is not possible to determine the cause of the appearance of ASD, but it is known that there is genetic implication. Currently there is no biological marker that allows the diagnosis

Read more